Nintedanib D3 Impurity | CAS 1624588-01-7 - Request Quote
Nintedanib D3 Impurity
| SZ CAT No: | SZ-N023D04 |
| CAS No | 1624588-01-7 |
| Mol.F. | C14H19D3N4O |
| Mol.Wt. | 265.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib D3 Impurity is chemically N-(4-Aminophenyl)-N-methyl-2-(4-(methyl-d3)piperazin-1-yl)acetamide. Nintedanib D3 Impurity is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib D3 Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1624588-01-7
Purchase 1624588-01-7
Order 1624588-01-7
Enquire 1624588-01-7
price of 1624588-01-7
1624588-01-7 Supplier
1624588-01-7 Manufacturer
1624588-01-7 Exporter
buy high quality Nintedanib D3 Impurity
Purchase Nintedanib D3 Impurity
Nintedanib D3 Impurity suppliers
Nintedanib D3 Impurity manufacturers
Nintedanib D3 Impurity price
Order Nintedanib D3 Impurity
Enquire Nintedanib D3 Impurity
Nintedanib D3 Impurity cost
Nintedanib D3 Impurity Supplier
Nintedanib D3 Impurity Distributor
Nintedanib D3 Impurity for Method Validation
Nintedanib Reference Standard
Nintedanib D3 Impurity for ANDA Filing
Nintedanib D3 Impurity for Forced Degradation Studies
Nintedanib D3 Impurity Identification Standards
Nintedanib D3 Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.